Publications by authors named "L Kaklamanis"

Introduction: Detection of mutations in primary tumors and liquid biopsy samples is of increasing importance for treatment decisions and therapy resistance in many types of cancer. The aim of the present study was to directly compare the efficacy of a relatively inexpensive ultrasensitive real-time PCR with the well-established and highly sensitive technology of ddPCR for the detection of the three most common hotspot mutations of , in exons 9 and 20, that are all of clinical importance in various types of cancer.

Patients And Methods: We analyzed 42 gDNAs from primary tumors (FFPEs), 29 plasma-cfDNA samples, and 29 paired CTC-derived gDNAs, all from patients with ER+ metastatic breast cancer, and plasma from 10 healthy donors.

View Article and Find Full Text PDF
Article Synopsis
  • Heart transplantation is the most effective treatment for advanced heart failure, but due to limited organ donation, many patients rely on left ventricular assist device (LVAD) implantation as a temporary solution.
  • A study of 68 advanced heart failure patients showed that those using the HeartMate 3 LVAD had better survival rates and fewer complications compared to those using the HeartWare device.
  • Out of the patients studied, 35 successfully received heart transplants, and the study highlighted the importance of reliable LVADs in improving patient outcomes while waiting for transplantation.
View Article and Find Full Text PDF

Determination of microsatellite instability (MSI)/mismatch repair (MMR) status in cancer has several clinical implications. Our aim was to integrate MSI/MMR status from patients tested in Greece to assess the prevalence of MSI-high (MSI-H)/deficient MMR (dMMR) per tumor type, testing patterns over time and concordance between MSI and MMR status. We retrospectively recorded MSI/MMR testing data of patients with diverse tumor types performed in pathology and molecular diagnostics laboratories across Greece.

View Article and Find Full Text PDF